|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1400 - 0.1500|
|52 Week Range||0.0800 - 0.9000|
|Beta (5Y Monthly)||-1.75|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 02, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Kelyniam Global, a leader in the design and manufacture of custom cranial implants, is pleased to announce that the United States Patent and Trademark Office has issued the company an Issue Notification for a patent covering the company's Integrated Fixation Tabs, currently marketed as IFS Tabs or KwikTabs. The US patent covers the integration of fixation appendages into a cranial implant and their design. The patent was filed in 2014 and will run through 2037.
Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its third quarter ended September 30, 2021.
Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, is pleased to announce that the company has submitted all of the documentation required for establishment as a "Pink Current" filer under the new SEC Rule 15c2-11 ahead of schedule for the September 30, 2021 deadline. The submission of information to the OTCIQ portal and achieving "Pink Current" filing status is in keeping with Kelyniam's commitment to transparency and shareholder disclosure.